HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helen of Troy

This article was originally published in The Rose Sheet

Executive Summary

Firm aims to build Idelle Labs division, which comprises grooming, skin care and hair care brands, in fiscal 2006, and will consider strategic personal care acquisitions, President & CEO Gerald Rubin reports during May 12 analyst call. Helen of Troy's personal care business struggled in fiscal Q4 (ended Feb. 28), with sales down 11% to $100.5 mil. Company expects the revitalization of the Brut men's grooming range and Sea Breeze skin care brand will help drive the segment going forward (1"The Rose Sheet" April 25, 2005, p. 9 and 2"The Rose Sheet" Jan. 17, 2005, p. 7). Net sales increased 13% to $127.6 mil. in Q4, while net earnings grew 59.4% to nearly $12 mil. However, net earnings from continuing operations fell 26.5% due to factors such as higher interest expense related to increased debt levels resulting from the June acquisition of OXO, firm says. Full-year sales grew 22.5% to $581.6 mil., and net earnings were up 26.5% to $76.5 mil. Net earnings from continuing operations grew 7.1%...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013048

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel